Navigation Links
Dr. Joseph L. Corriveau Appointed Director of Research and Technology
Date:12/19/2007

ABERDEEN PROVING GROUND, Md., Dec. 19 /PRNewswire/ -- Dr. Joseph Corriveau was recently appointed Director of Research and Technology for the Edgewood Chemical Biological Center (ECBC). With this appointment, Dr. Corriveau will enter the Senior Executive Service (SES). Members of the SES serve in key positions just below top Presidential appointees and are the major link between the appointees and the federal work force.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071219/NEW083LOGO )

As the new Director of Research and Technology, Dr. Corriveau will be responsible for the scientific activities of Department of the Army civilian employees and on-site contractor personnel who are part of ECBC's Research and Technology Directorate. The directorate, one of three within ECBC, supports the Department of Defense, as well as other government agencies by providing innovative science and technology solutions for chemical and biological defense.

Dr. Corriveau joined ECBC in June 2003 as the Deputy Director for Research and Technology after serving in the Office of the Under Secretary of Defense for Acquisition, Technology & Logistics as the chief scientist for the Chemical Biological Defense Program. Earlier in his career, Dr. Corriveau served as a senior analyst with the Army's National Ground Intelligence Center. He is viewed as the Department of Defense's expert in emerging threats.

Dr. Corriveau holds two degrees from Brown University: a Doctorate in Biology with an emphasis in cell and molecular biology, and a Master of Science in Biology with an emphasis in biochemistry. He also holds a Master of Science in Plant Pathology from the University of Delaware, and a Bachelor of Arts in Biology from Saint Anselm College.

An appointment ceremony will be held in January. A photo of Dr. Corriveau is available at http://www.ecbc.army.mil/pr/pr.htm.

ECBC is the Army's principal research and development center for chemical and biological defense technology, engineering and field operations. ECBC has achieved major technological advances for the warfighter and for our national defense, with a long and distinguished history of providing the Armed Forces with quality systems and outstanding customer service. ECBC is a US Army Research, Development and Engineering Command laboratory located at the Edgewood Area of Aberdeen Proving Ground, Maryland. For more information about the Edgewood Chemical Biological Center, please visit our Web site at http://www.ecbc.army.mil or call (410) 436-3610.


'/>"/>
SOURCE Edgewood Chemical Biological Center
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
2. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
5. John Marshall and Kevin McGuinness Appointed to Ellex Board
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. David Mott Appointed Non Executive Director at Shire
8. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
9. Third Security, LLC Hires Two New Managing Directors
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. Codexis Appoints Singapore Laboratories Managing Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):